CIK 0001398733
- Non-accelerated filer
- Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208623253
- Phone
- +1 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 4 Planned sale Chief Operating Officer sold 62,180 shares at $5.00 ($310,900)
- 4 Planned sale See Remarks sold 15,000 shares at $5.30 ($79,500)
- 4 Grant or award Chief Commercial Officer acquired 25,000 shares (grant or award)
- 4 Shares withheld for taxes Chief Medical Officer gave up 10,819 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes SVP Sales and Marketing gave up 2,714 shares (to pay taxes)
- 4 Grant or award SVP, Regulatory Affairs acquired 20,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Science Officer gave up 32,862 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 17,540 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 18,929 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 8,115 shares (to pay taxes)
- 4 Shares withheld for taxes SVP Sales and Marketing gave up 5,428 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 20,250 shares (to pay taxes)
- 4 Shares withheld for taxes See Remark gave up 14,305 shares (to pay taxes)
Page 4 of 17 · 326 filings